Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose pegvisomant add-on in controlled acromegaly
NL-OMON24812Not yet recruiting
- Sponsor
- Erasmus University MC Dept. of Medicine PO Box 2040 3000 CA Rotterdam NL Tel: +31 10 703 2862
- Start
- Dec 2011
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Randomised, double-blind trial of pegvisomant in acromegaly, sponsored by Erasmus University MC Dept. of Medicine PO Box 2040 3000 CA Rotterdam NL Tel: +31 10 703 2862. Planned start Dec 2011; status: not yet recruiting.
02
Drugs
pegvisomant
03
Conditions
acromegaly
Beyond the preview
Go deeper on NL-OMON24812.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON24812.